Menglin Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Menglin Zhao has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Fang Yan
College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China
1 shared publication - Tiecheng Wang
Key Laboratory of Jilin Province for Zoonoses Prevention and Control, State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, China
1 shared publication - Weiyang Sun
Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun 130122, China
1 shared publication - Xianzhu Xia
Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun 130122, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, PR China
1 shared publication - Yeting Xia
College of Life Sciences, Henan University, Kaifeng 475004, China
1 shared publication - Yue Feng
Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun 130122, China; College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China
1 shared publication
Latest Publications
- Open Access
- 2 April 2026
- Published by Elsevier in Virus Research
- Vol. 367, 199722
The influenza B virus candidate vaccine expressing H3 hemagglutinin developed in suspension MDCK cells confers protection against lethal H3N2 avian influenza in BALB/c mice
- 2 April 2026
- Published by Elsevier in Virus Research
- Vol. 367, 199722
Open AccessThe influenza B virus candidate vaccine expressing H3 hemagglutinin developed in suspension MDCK cells confers protection against lethal H3N2 avian influenza in BALB/c mice